Zdrowie i gospodarka · 12/12/2000

FDA Amends Regulations for Anti-Human Globulin and Blood Grouping Reagents

The Food and Drug Administration (FDA) is removing the requirement for sterile products in licensed Anti-Human Globulin (AHG) and Blood Grouping Reagents (BGR), citing that this requirement is not necessary for the products to be safe, pure, and potent.